For children, separate trials are organised only when safety and efficacy data have already been obtained for adults.
It is essential for new molecules also to be tested in children. We cannot simply content ourselves with adapting adult doses, and side effects may be completely different. In addition, if there are no paediatric studies, children will have no access to new medicines.
Update: October 2015